데이터가 없습니다.

1. The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma [ Clinical Lymphoma Myeloma & Leukemia ] - 2024.03.01
2. DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 [ GASTRIC CANCER ] - 2024.01.01
3. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study [ Molecular Cancer ] - 2023.12.09
4. Prognostic significance of 25-hydroxyvitamin D levels in patients with peripheral T-cell lymphoma. [ LEUKEMIA & LYMPHOMA ] - 2023.12.01
5. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404) [ CANCER RESEARCH AND TREATMENT ] - 2023.04.01
6. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK [ CANCER RESEARCH AND TREATMENT ] - 2023.01.01
7. Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study [ OncoImmunology ] - 2022.11.23
8. Modified Stage Grouping of Diffuse Large B-Cell Lymphoma Involving the Same Side of the Diaphragm in the Rituximab Era [ FRONTIERS IN ONCOLOGY ] - 2022.05.27
9. Diagnosis and management of monoclonal gammopathy of clinical significance [ Blood research ] - 2022.04.30
10. BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis [ MODERN PATHOLOGY ] - 2022.04.01
11. 21세기 다발골수종의 단일 기관 현실 세계 경험 [ 대한내과학회지 ] - 2022.04.01
12. Prognostic value of natural killer cell activity for patients with HER2+advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab [ CANCER IMMUNOLOGY IMMUNOTHERAPY ] - 2022.04.01
13. Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis [ BLOOD ADVANCES ] - 2021.04.27
14. 림프종과 골수종 환자에서 자가 조혈모세포 이식술의 현실 세계 경험 [ 대한내과학회지 ] - 2021.04.07

1. 재발성 또는 불응성 미만성 거대 B 세포 림프종(DLBCL) 시험대상자들에서 레날리도마이드, 리툭시맙과 병용 투여하는 브렌툭시맙 베도틴 또는 위약의 무작위 배정, 이중 눈가림, 위약 대조, 활성 대조약, 다기관, 제 3 상 임상시험 - 2021.04.07 ~ 2025.05.30

데이터가 없습니다.

      데이터가 없습니다.

 공지